NCT04800822 2024-10-22PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT02961283 2023-05-09Study of ASN003 in Subjects With Advanced Solid TumorsAsana BioSciencesPhase 1 Terminated24 enrolled